1 |
毛雷音,傅育红,徐颢庭.加速康复理念下高龄髋部骨折围手术期饮食方案的制定及应用研究[J/CD].中华老年骨科与康复电子杂志, 2020, 6(6): 357-363.
|
2 |
常晓,张保中,翁习生,等.高龄髋部骨折术后院内死亡的危险因素分析[J/CD].中华老年骨科与康复电子杂志, 2017, 3(1): 43-49.
|
3 |
梁伟,吴斗,赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J/CD].中华老年骨科与康复电子杂志, 2018, 4(3): 184-188.
|
4 |
Tanaka K, Yamagata K, Kubo S, et al. Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10 [J]. Bone, 2019, 128: 115034.
|
5 |
Thomas CJ, Cleland TP, Sroga GE. Accumulation of carboxymethyllysine (CML) in human cortical bone [J]. Bone, 2018, 110: 128-133.
|
6 |
Choi DH, Lee SM, Lim SA, et al. Feasibility of serum pentosidine level as a potential risk factor for osteoporotic vertebral compression fracture [J]. Asian Spine J, 2018, 12(6): 992-997.
|
7 |
Tamaki J, Kouda K, Fujita Y, et al. Ratio of endogenous secretory receptor for advanced glycation end products to pentosidine predicts fractures in men [J]. J Clin Endocrinol Metab, 2018, 103(1): 85-94.
|
8 |
Shiraki M, Kashiwabara S, Imai T, et al. The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women [J]. J Bone Miner Metab, 2019, 37(6): 1067-1074.
|
9 |
Creecy A, Uppuganti S, Girard MR, et al. The age-related decrease in material properties of BALB/c mouse long bones involves alterations to the extracellular matrix [J]. Bone, 2020, 130: 115126.
|
10 |
Saito M, Fujii K, Mori Y, et al. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats [J]. Osteoporos Int, 2006, 17(10): 1514-1523.
|
11 |
Allen MR, Gineyts E, Leeming DJ, et al. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra [J]. Osteoporos Int, 2008, 19(3): 329-337.
|
12 |
Plotkin L, Essex AL, Davis HM. RAGE signaling in skeletal biology [J]. Curr Osteoporos Rep, 2019, 17(1): 16-25.
|
13 |
Ohishi T, Fujita T, Suzuki D, et al. Changes of bone mineral density and serum pentosidine during a 27-month follow-up of monthly minodronate in osteoporotic patients [J]. Endocr Res, 2017, 42(3): 232-240.
|
14 |
Prasad K. AGE-RAGE stress play a role in aortic aneurysm: A comprehensive review and novel potential therapeutic target [J]. Rev Cardiovasc Med, 2019, 20(4): 201-208.
|
15 |
Ebert H, Lacruz ME, Kluttig A, et al. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort [J]. BMC Geriatr, 2019, 19(1): 299.
|
16 |
Thomas MC, Söderlund J, Lehto M, et al. Soluble receptor for AGE (RAGE) is a novel Independent predictor of all-cause and cardiovascular mortality in type 1 diabetes [J]. Diabetologia, 2011, 54(10): 2669-2677.
|
17 |
Selvin E, Halushka MK, Rawlings AM, et al. sRAGE and risk of diabetes, cardiovascular disease, and death [J]. Diabetes, 2013, 62(6): 2116-2121.
|
18 |
Galliera E, Marazzi MG, Gazzaruso C, et al. Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study [J]. Immun Ageing, 2017, 14: 13.
|